BOSTON – Attorney General Martha Coakley’s office announced last week that it had joined 37 other states in a $90 million settlement with GlaxoSmithKline LLC. The lawsuit resolves allegations that the pharmaceutical company unlawfully promoted its diabetes drug, Avandia, by misrepresenting its cardiovascular risks and safety profile. According to a statement, the settlement will bring more than $2.1 million to the commonwealth. more

While unlikely to ever make a dent in Rhode Island’s stubbornly high unemployment rate, there is a feel-good vibe being built by the growing number of custom-bicycle fabricators in Providence. more

The custom bicycle frames being built by hand at Circle A Cycles in Providence combine the old and the new. more

Profits for Astro-Med Inc. surged 63.5 percent to $1.3 million, or 18 cents per diluted share, during the third quarter of 2012, compared with $800,000, or 11 cents per diluted share, during the third quarter of 2011. more

Dama Inc. will collaborate with LeachGarner, a Berkshire Hathaway company, to bring new findings, including a new secure clutch and post earring back system, to the jewelry market. more

Industrial production in the U.S. unexpectedly declined in October as superstorm Sandy knocked out power in the Northeast. more

Juvenile health, safety and wellness product maker Summer Infant Inc. posted a net loss of $65.4 million, or $3.65 per diluted share, for the three months ended Sept. 30, compared with a $2.1 million, or 11 cents per diluted share, gain during the same period in 2011. more

Medical technology maker Covidien PLC reported fourth-quarter earnings of $461 million, or 95 cents per diluted share, a rise of 2.2 percent from the $451 million, or 92 cents per diluted share reported during the same period in 2011. more

For years, electroplating and jewelry manufacturing were the bread and butter of Providence’s industrial base. Along with textiles, they were the main source of employment for many Rhode Island families. more

Nortek Inc. reported net income of $4.7 million, or 30 cents per diluted share, during the third quarter of 2012, compared with a net loss of $2.1 million, or 14 cents per diluted share a year earlier, the company announced late Thursday. more